Senores Pharmaceuticals Limited has informed the exchange regarding Submission of Secretarial Compliance Report for the financial year ended on March 31, 2025
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, to BSE and NSE as required under SEBI's Listing Regulations. The report was prepared by Mukesh H. Shah & Co., Company Secretaries and confirms that the company has generally complied with all material provisions of applicable SEBI regulations. It notes that no actions have been taken against the company, its promoters, directors, or material subsidiaries by SEBI or the stock exchanges during the review period. The company's shares have been listed on BSE and NSE since December 30, 2024, and all compliance areas checked — including secretarial standards, policies, website disclosures, related party transactions, and insider trading — were found to be in order.
This is a routine annual compliance filing with a clean report — no penalties, observations, or regulatory actions reported. It signals good corporate governance standing but is unlikely to move the stock price as it carries no new financial information.